Close Menu

If you feel like depressing yourself today, check out this blog post from Derek Lowe at In the Pipeline. Lowe points to an analysis performed on a clinical trial for gabapentin (marketed by Pfizer under the name Neurontin) in the '90s. "The authors find, by analyzing a large trove of documents released during lawsuit discovery proceedings, that [the clinical trial] was not really intended to be a clinical trial. Instead, it was a marketing program," Lowe writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.